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Abstract
Introduction: Despite tight glycemic control, pregnancy complication rate in type 1 diabetes patients is higher than in
normal pregnancy. Other etiological factors may be responsible for the development of adverse pregnancy outcome.
Acceptance of the semi-allogeneic fetus is accompanied by adaptations in the maternal immune-response. Maladaptations
of the immune-response has been shown to contribute to pregnancy complications. We hypothesized that type 1 diabetes,
as an autoimmune disease, may be associated with maladaptations of the immune-response to pregnancy, possibly
resulting in pregnancy complications.
Methods: We studied pregnancy outcome and pregnancy-induced immunological adaptations in a normoglycemic rat-
model of type 1 diabetes, i.e. biobreeding diabetes-prone rats (BBDP; 5 non-pregnant rats, 7 pregnant day 10 rats and 6
pregnant day 18 rats) , versus non-diabetic control rats (i.e. congenic non-diabetic biobreeding diabetes-resistant (BBDR; 6
non-pregnant rats, 6 pregnant day 10 rats and 6 pregnant day 18 rats) and Wistar-rats (6 non-pregnant, 6 pregnant day 10
rats and 5 pregnant day 18 rats)).
Results: We observed reduced litter size, lower fetal weight of viable fetuses and increased numbers of resorptions versus
control rats. These complications are accompanied by various differences in the immune-response between BBDP and
control rats in both pregnant and non-pregnant animals. The immune-response in non-pregnant BBDP-rats was
characterized by decreased percentages of lymphocytes, increased percentages of effector T-cells, regulatory T-cells and
natural killer cells, an increased Th1/Th2-ratio and activated monocytes versus Wistar and BBDR-rats. Furthermore,
pregnancy-induced adaptations in BBDP-rats coincided with an increased Th1/Th2-ratio, a decreased mean fluorescence
intensity CD161a/NKR-P1b ratio and no further activation of monocytes versus non-diabetic control rats.
Conclusion: This study suggests that even in the face of strict normoglycemia, pregnancy complications still occur in type 1
diabetic pregnancies. This adverse pregnancy outcome may be related to the aberrant immunological adaptations to
pregnancy in diabetic rats.
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Introduction
Type 1 diabetes mellitus (T1D) during pregnancy is associated
with adverse pregnancy outcome, such as pre-eclampsia, prema-
turity, macrosomia and perinatal death [1,2]. Up to now, this has
been attributed to frequent episodes of hyperglycemia [3,4]. This
argumentation was supported by the observation that improved
metabolic control before and during pregnancy in women with
type 1 diabetes decreased the number of pregnancy complications.
However, even under adequate glycemic control, complication
rate is still increased [1,5], suggesting that other etiological
mechanisms may be involved. A possible candidate may be
immunological changes associated with this autoimmune disease
in these women [6,7].
Acceptance of the semi-allogeneic fetus during normal preg-
nancy is facilitated by adaptations in the maternal peripheral and
local immune-responses [7]. Peripherally, innate immune cells
become activated during pregnancy as characterized by upregula-
tion of various activation markers on monocytes and granulocytes
and changes in cytokine secretion [8,9]. The specific immune-
response shifts from a type 1 (i.e. cellular; Th1) immune-response
towards a type 2 (i.e. humoral; Th2) immune-response [10,11].
The adaptations at the local level are accompanied by an influx of
Natural Killer (NK) cells into the decidua. Further, macrophages
infiltrate the decidua as well and differentiate towards the M2
phenotype, which have immunosuppressive properties [12,13].
Altered adaptations in these immune-responses to pregnancy may
induce maternal and perinatal complications, like pre-eclampsia,
pregnancy-induced hypertension, intrauterine growth retardation,
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preterm delivery and/or abortion [14–18]. Disturbances of the
immune response at the local level may lead to impaired
placentation, resulting in, for instance, pre-eclampsia [19].
Disorders of the immune response at the peripheral level are
linked to the development of (cardio)vascular diseases, such as
hypertension [20].
Type 1 diabetes is an auto-immune disease with many
immunological changes as compared to healthy individuals;
previous studies showed a shift towards a Th1 immune-response,
decreased number and/or function of Treg [21], decreased
number of NK cells [22,23], and activation of monocytes [24] in
patients with type 1 diabetes versus healthy individuals. The
question therefore rises if the immune-response of type 1 diabetic
patients is able to face the necessary immunological changes
during pregnancy. Hence, we hypothesized that in type 1 diabetes
the immunological adaptations to pregnancy might be disturbed
and therefore contribute to higher frequency of maternal and
perinatal pregnancy complications.
To test our hypothesis we applied a rat-model of type 1 diabetes,
the biobreeding diabetes-prone (BBDP) rat, to study adaptations of
the peripheral immune-response to pregnancy. This model is
generally accepted as a model for type 1 diabetes and well
controlled in terms of immunological changes and lack overshad-
owing secondary effects of medication and heterogeneity in
responses in human population. Moreover, BBDP-rats were kept
strictly normoglycemic during pregnancy using insulin pellets, to
avoid the influence of hyperglycemia. We used congenic non-
diabetic biobreeding diabetes-resistant (BBDR) and Wistar-rats (as
the parent strain of BBDP and BBDR-rats) as controls.
Materials and Methods
Experimental design and animals
Approval of the institutional Animal Care Ethics Committee,
University of Groningen (application-number DEC-5759a) was
obtained; all animals received human care in compliance with
Dutch Law on Experimental Animal Care. Figure 1 shows the
experimental design. Female rats of three different strains were
used: Biobreeding diabetes-prone (BBDP) rats, which develop type
1 diabetes spontaneously between 60–120 days after birth; animals
were only used after diabetes was established. Congenic biobreed-
ing diabetes-resistant (BBDR) rats which do not spontaneously
develop diabetes and act, therefore, as a control model. However,
since BBDR-rats are sensitive to diabetes induction due to viral
infection, depletion of regulatory T cells or Toll-like receptor
ligation [25], we used Wistar (W) rats, the parent strain of BBDP
and BBDR-rats [25], which are not sensitive to diabetes induction,
as our absolute controls. BBDP and BBDR-rats were bred and
nurtured at the Central Animal Facility of the UMCG [26]. All
rats (age 3–6 months and weighing 200–250 gr) were kept in
temperature- and light-controlled environment (lights on from 6
AM to 6 PM). Vaginal smears were taken daily to assess ovarian
cyclicity. Pregnancy was achieved by housing female rats on the
night of pro-estrus with a fertile male. The next day, when
spermatozoa were detected in the smear, was pregnancy day 0.
Non-pregnant animals were sacrificed on di-estrus.
BBDP-rats were weighed three times a week from 50 days of
age. After a decrease in bodyweight, glucose was measured in tail-
vein blood using a glucose-sensor (Accu-Check Sensor Comfort,
Roche Diagnostics Nederland B.V., Almere, The Netherlands)).
After establishing diabetes in BBDP-rats (blood glucose
.15 mmol/L), rats received a half insulin implant (Linplant-
sustained-release-insulin-implant; LinShin Canada Inc, Toronto,
Canada) subcutaneously, to maintain blood glucose ,5.5 mmol/
L. To prevent hypoglycemia due to an excess amount of insulin,
we implanted a half insulin implant, which released about 1 unit/
24 hr. In our experience half an insulin implant will keep the
BBDP-rats normoglycemic for 3–4 weeks. These insulin treated
non-pregnant diabetic rats were weighed 3 times a week and blood
glucose was measured at least once every 3 weeks as well as in case
of weight loss. Blood glucose was always between 4.5 and
5.5 mmol/L, except when weight loss occurred, which was always
associated with hyperglycemia. An additional half insulin pellet
was implanted if glucose rose again .10 mmol/L. Due to
maternal weight gain during pregnancy, we could not only rely
on maternal weight gain for estimating blood glucose. Therefore,
apart from measuring maternal weight gain every day, blood
glucose of pregnant diabetic rats was measured 3 times a week.
Also in these animals, blood glucose remained between 4.5 and
5.5 mmol/L, lack of weight gain as well as weight loss was
associated with hyperglycemia. If blood glucose rose above
5.5 mmol/L, rats received an additional half insulin implant.
Power analysis using the general variance of immune param-
eters in Wistar rats (i.e. about 10%) and a physiologically relevant
effect size of 20% with a= 0.05 and ß = 0.8, revealed an n = 5 per
group. We included 6 rats in each group. Unfortunately, 1
pregnant W rat appeared to be pseudopregnant rather than
pregnant and was excluded from the study, and 1 non-pregnant
BBDP rat turned out to be pregnant and was moved to the
pregnant group). For all rats strains we included non-pregnant rats
(BBDP: n = 5; W: n = 6; BBDR: n = 6), and pregnant rats at day 10
(BBDP: n = 7; W: n = 6; BBDR: n = 6) and at day 18 (BBDP: n = 6;
W: n = 5; BBDR: n = 6). At the day of sacrifice, rats were
anesthetized with isofluorane/O2, and blood was collected from
the aorta into 10 ml EDTA tubes (BD-Plymouth, UK). We
counted number of implantations sites for day 10 (d10) pregnant
rats. For day 18 (d18) pregnant rats, we counted number of viable
fetuses and number of resorptions, weighed individual placentas
and fetuses and checked these for major abnormalities.
Sample handling
White Blood Cell (WBC) counts. Twenty ml of blood was
diluted in 500 ml PocH-buffer and leukocytes were counted using a
microcell counter (Sysmex PocH 100i, Sysmex Netherlands).
Reagents. The following reagents were used: Washing-buffer
(phosphate-buffered saline (PBS) with 0.5% bovine serum albumin
and 0.1% NaN3), FACS
TM lysing buffer solution (BD Biosciences,
Breda, the Netherlands), FoxP3-staining buffer set (eBioscience,
Vienna, Austria), complete RPMI-1640 medium (Lonza Benelux,
Breda, the Netherlands) supplemented with 60 mg/ml gentamycin
(Invitrogen, Breda, the Netherlands), Lymphoprep (Axis-shield
PoC-As, Oslo, Norway), TRIzol Reagent (Invitrogen), Absolute
QPCR ROX Mix (Westburg, Leusden, the Netherlands) and
RNase-free water (Qiagen, Hilden, Germany).
Antibodies. The following antibody-cocktails were used to
stain different leukocytes subsets and their activational status.
Unless stated otherwise, they were purchased from BioLegend
(BioLegend Europe, Uithoorn, the Netherlands).
In the T-lymphocyte cocktail the following antibodies were
used: Mouse-anti-rat CD3 Biotin-labeled (clone eBioG4.18;
eBioscience, Frankfurt, Germany), mouse-anti-rat CD4 Alexa-
Fluor700-labeled (clone W3/25; AbD Serotec, Germany), mouse-
anti-rat CD25 FITC-labeled (clone Il-2R; BD Pharmingen, Breda,
Netherlands), Rat-anti-mouse/rat FoxP3 APC-labeled (clone FJK,
eBioscience) and Rat-APC-labeled isotype control IgGG2a (clone
eBR2a, eBioscience) and PerCP-labeled streptavidin.
In the Natural Killer cells cocktail the following antibodies were
used: Mouse-anti-rat NKRP1a/CD161a PE-labeled (clone 10/78;
Immunity in Pregnant Type 1 Diabetic Rats
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BD Pharmingen), Mouse-anti-rat NKRP1b Biotin-labeled (clone
STOK27: Kindly donated by J.T. Vaage, Institute of Immunol-
ogy, Rikshospitalet University Hospital, Oslo, Norway) and
PerCP-labeled streptavidin.
In the monocytes cocktail the following antibodies were used:
Mouse-anti-rat CD172a PE-labeled (clone OX-41), Mouse-anti-
rat CD43 AlexaFluor647-labeled (clone W3/13) and FITC-
labeled anti-rat CD4 (clone OX-35; BD Pharmingen).
Sample labeling. Immediately after sampling, 1200 ml whole
blood was mixed with 1200 ml RPMI-1640 after which samples
were aliquoted (200 ml per tube) into eleven tubes (six for
compensation of the flowcytometry, 2 for lymphocytes/lympho-
cyte isotype cocktail, 1 for NK-cell cocktail, 2 for monocytes/
monocytes isotype cocktail) followed by centrifugation and
aspiration of plasma. Subsequently, all tubes were incubated with
antibodies (-cocktails) in dark for 30 min and washed. Thereafter,
tubes were either incubated with PerCP-labeled streptavidin or
with washing-buffer for 15 minutes in dark followed by lysis of red
blood cells (RBC) using lysing buffer for 30 minutes in the dark.
After centrifugation, aspiration and washing, tubes for lympho-
cyte/lymphocyte isotype were incubated with 200 ml fixperm,
while 300 ml washing-buffer was added to the other tubes which
were stored at 4uC in dark. After 30 min incubation at RT in dark,
tubes for lymphocyte/lymphocyte isotype were washed with
200 ml perm followed by incubation with FoxP3 antibody or its
isotype for 30 min at RT in dark and washed with 1 ml perm
afterwards. Finally, 300 ml washing-buffer was added to these
tubes and tubes were stored at 4uC in dark. Flow cytometry was
done within 24 hr.
Flow cytometry
Two hundred fifty thousand events were counted using the
BDTM LSR II flow cytometer (BD Biosciences), and data were
saved for later analysis. Analysis was performed using FlowJo 7.6.1
(Tree Star, Inc., Ashland, OR, USA).
Differential cell counts. First, we assessed percentages of
different leukocyte populations. A gate was set around leukocytes
in the forward/sideward (FSC/SSC) scatter-plot, which was
copied to a CD43/CD172a plot. Lymphocytes are CD172a
negative. Although monocytes and granulocytes are both CD172a
positive, monocytes show a stronger CD172a expression and
weaker CD43 expression as compared to granulocytes. Therefore,
this plot allowed us to select monocytes (CD172a++/CD432/+),
granulocytes (CD172a+/CD43+) and lymphocytes (CD172a2).
Percentages of these subpopulations from total leukocyte popula-
tion were calculated.
Lymphocytes. To identify percentages of various lymphocyte
populations, a gate was around leukocytes in a FSC/SSC plot
(Figure 2A). This gate was copied to a new FSC/SSC plot and
lymphocytes were identified (Fig. 2B). These lymphocytes were
copied into a SSC/CD3 graph to identify T-lymphocytes (SSC/
CD3+; Fig. 2C). This T-lymphocyte gate was copied to a CD3/
CD4 scatter-plot (Fig. 2D). Subsequent gates were set on CD3+/
CD4+ lymphocytes (T-helper lymphocytes; Th) and the CD3+/
CD42 population (T-cytotoxic lymphocytes; Tc). The Th/Tc
ratio was calculated by dividing the percentage Th by the
percentage Tc. To distinguish CD25 positive and negative cells,
gates were set based on FITC-positivity of CD32 cells in such a
way that 99% of these cells were negative for CD25 (Fig. 2E); the
CD3+/CD4+ gate was copied to a CD4/CD25 scatter-plot
(Fig. 2F). The populations CD3+/CD4+/CD25+ and CD3+/
CD4+/CD252 were identified as effector T-lymphocytes (Teff)
and naive helper cells respectively. Regulatory T-cells (Treg) were
identified as CD3+/CD4+/CD25+/FoxP3+ (Fig. 2G).
NK-cells. To identify NK-cells, a gate was set around
leukocytes in a FSC/SSC plot. This gate was copied to a new
Figure 1. Flowchart of the experimental design.
doi:10.1371/journal.pone.0065490.g001
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FSC/SSC plot to identify lymphocytes. The lymphocyte gate was
copied to a CD161a/SSC plot (CD161a or NKR-P1a is an
activating receptor and present on all NK-cells); a gate was set on
CD161a+. These cells were identified as NK-cells. Further, mean
fluorescence intensity (MFI) of this stimulatory receptor CD161a
and MFI of the inhibitory receptor (i.e. NKR-P1b) on these NK-
cells was assessed. The MFI ratio of CD161a/NKR-P1b reveals
the balance of stimulatory/inhibitory receptors.
Monocytes. To analyze monocyte subsets, a gate was set
around leukocytes in a FSC/SSC plot. This gate was copied to a
CD43/CD172a plot, and a subsequent gate was set on CD172a++
cells (monocytes). This gate was copied to a new CD172a/CD43
Figure 2. An representative example of a FACS analysis procedure to evaluate lymphocytes subpopulations. [A] A forward/sideward
(FSC/SSC) scatterplot of all events in which leukocytes were identified. [B] The leukocyte gate was copied to a FSC/SSC scatterplot in which the
lymphocytes are identified. [C] These lymphocytes are copied to a SSC/CD3-PerCP scatterplot to distinguish T-lymphocytes (CD3+). [D] The
lymphocytes are further divided into helper (CD3+/CD4+) and cytotoxic (CD3+/CD4+; ct) T-cells in a CD3 PerCP/CD4 Alexa 700 scatterplot. [E] A CD3
PerCP/CD25 FITC scatterplot in which CD32 cells were copied to assess the gate for FITC-positivity. [F] This gate for FITC positivity was copied to a
CD4 Alexa 700/CD25 FITC scatterplot to identify CD25 positive and negative cells; i.e. effector (CD3+/CD4+/CD25+) and naive helper T-cells (CD3+/
CD4+/CD252). [G] A CD25 FITC/FoxP3 Alexa 647 scatterplot to identify the regulatory T-cell (CD3+/CD4+/CD25+/FoxP3+; Treg) positive population.
doi:10.1371/journal.pone.0065490.g002
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plot and gates were set on CD172a++/CD43+ and CD172a++/
CD43++ (classical and non-classical monocytes, respectively). The
percentages of CD4 positive cells and CD4 MFI were measured in
each subpopulation to analyze activation-status of these subpopu-
lations.
Messenger-RNA (mRNA) analysis.
The remainder of the blood sample was diluted 1:1 with PBS
and peripheral blood mononuclear cells (PBMC) were isolated
using lymphoprep. After washing, the PBMC’s were resuspended
in 1ml of TRIzol and frozen at 280uC until further analysis. Total
RNA was extracted by chloroform-isopropanol according to the
manufacturer’s protocol. cDNA was reverse transcribed using
Superscript-II reverse-transcriptase kit (Invitrogen Life Technolo-
gies) according to manufacturer’s protocol.
Taqman Gene Expression Assays (Applied Biosystems, Carlsbad,
CA, USA) were used. Three housekeeping genes, i.e. 1) b-Actin
(Rn00667869_m1), 2) B2M (Rn00560865_m1) and 3) GAPDH
(Rn01775763_g1) and three genes were assessed, i.e. 1) Tbx21 (Th1
transcription-factor; Rn01461633_m1), 2) GATA-3 (Th2 transcrip-
tion-factor; Rn00484683_m1) and 3) ROR-C (Th17 transcription-
factor; Rn01533717_g1). Real-time RT-PCRs were performed in
triplicate in 20 ml according to Applied Biosystems protocol. Runs
were performed by a 7900HT Fast real-time PCR system (Applied
Biosystems), under standard conditions. Variance of housekeeping
genes was tested using NormFinder [27]. As GAPDH showed the
least variance between non-pregnant and pregnant groups, mRNA
data were normalized to GAPDH mRNA using DCt = CtGENE OF
INTEREST – CtGAPDH. Gene data are expressed as 2
2DCt. The Th1/
Th2 ratio was calculated by dividing Tbx21 gene expression by
GATA-3 gene expression.
Statistics
Continuous parameters were expressed as median (Q1–Q3). To
compare differences between the 3 non-pregnant strains of rats,
Mann-Whitney U-test was used. To evaluate pregnancy-induced
differences, linear regression analysis was performed. The slope of
the regression line through data of non-pregnant, pregnant day 10
and 18 was calculated and it was tested (by analyzing the covariance;
ANCOVA) whether the slope was significantly different from zero
or significantly different between different strains. P-values of,0.05
were considered as statistically significant and p-values between
0.05–0.1 as a trend. Bonferroni correction was used to correct for
multiple comparisons. In order to show pregnancy effects, median of
non-pregnant parameters was set at 100% and percentages from day
10 and day 18 were recalculated from non-pregnant data using
ratios and proportions (a/b = c/d). Statistical analyses were
performed using PASW for Windows version 18 (SPSS, Inc.,
Chicago, IL, USA) and GraphPad Prism 5 for windows (GraphPad
Software, Inc., La Jolla, Ca, USA).
Results
Higher frequency of fetal complications in BBDP-rats
We first evaluated fetal weight and resorptions in normoglycemic
BBDP-rats and our controls. A trend towards decreased number of
implantation sites was found in pregnant d10 BBDP-rats as
compared to d10 W-rats (Table 1). At d18, number and weight of
viable fetuses and placentas was significantly lower and number of
resorptions was significantly higher in BBDP-rats as compared to W-
rats. With respect to the pregnancy outcome of BBDR-rats, the
results of this strain were between BBDP and W-rats.
To assess pregnancy-induced adaptations of the immune-
response, we first evaluated the immune-response in the 3 non-
pregnant rat strains; this is the immune-response at fertilization. In
general, our main focus was on differences between BBDP and W-
rats, since W-rats are our absolute controls. However our graphs
also show comparisons between BBDR-rats and BBDP or W-rats.
Decreased WBC and lymphocytes in BBDP-rats
WBC counts and percentages of different leukocyte subsets were
significantly lower in non-pregnant BBDP-rats as compared to W-
rats (Table 2).
Increased percentage of effector and regulatory T-cells
and NK-cells in non-pregnant BBDP-rat
Although the percentage of T-lymphocytes is decreased in BBDP-
rats vs. W-rats, the Th/Tc ratio was not affected (Fig. 3A).
Moreover, we observed an increased percentage of effector T-cells
(and a decreased percentage of naı¨ve T-cells (not shown)) and
regulatory T-cells (Treg) in BBDP vs. W-rats. Also NK-cell numbers
were different between the strains: the percentage of NK-cells was
increased in BBDP-rats as compared to W-rats, although the MFI
ratio CD161a/NKR-P1b was similar between these strains.
Increased Th1/Th2 ratio in non-pregnant BBDP-rats
Since we found differences in T-cell frequencies between BBDP-
rats and W-rats, we evaluated the Th1-, Th2- and Th17-response,
Table 1. Basic characteristics of the different rat strains.
BBDP Wistar BBDR
d10 (n=7) d18 (n =6) d10 (n=6) d18 (n =5) d10 (n=6) d18 (n=6)
Number of implantation
sites/viable fetuses
8.0(3.0–10.0) 6.0(4.0–8.0) 14.0(8.3–14.3){ 12.0(11.0–15.0)* 9.5(4.8–10.8) 8.5(6.3–12.0)1
Number of resorptions n/a 2.5(0.8–3.0) n/a 0.0(0.0–0.0)* n/a 0.0(0.0–1.0){
Maternal weight gain (gr.) 19.0(14.0–26.0) 59.0(56.5–64.3) 39.5(34.5–43.3)* 100.0(87.5–109.0)* 23.5(20.3–26.0)` 70.5(60.8–77.0)`
Weight of pups (gr.) n/a 0.896(0.867–0.993) n/a 1.177(1.124–1.239)* n/a 1.087(1.065–1.108)*`
Placental weight (gr.) n/a 0.371(0.313) n/a 0.454(0.424–0.550)* n/a 0.475(0.384–0.512){
Values are expressed as median (Q1–Q3). Abbreviations: d10 = sacrificed at day 10 of pregnancy, d18 = sacrificed at day 18 of pregnancy.
*: significantly different from the BBDP-rats at the same gestational age (Mann-Whitney U-test; p,0.05).
{: statistical trend as compared with BBDP-rats at the same gestational age (Mann-Whitney U-test; p = 0.10–0.05).
`: significantly different from W-rats at the same gestational age (Mann-Whitney U-test; p,0.05).
1: statistical trend as compared with W-rats at the same gestational age (Mann-Whitney U-test; p = 0.10–0.05). The immune-response of non-pregnant BBDP-rats.
doi:10.1371/journal.pone.0065490.t001
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which are important for healthy pregnancy, by measuring
transcription factors specific for Th1 (Tbx21), Th2 (GATA-3) and
Th17 (ROR-C) cells (Fig. 3B). The ratio Tbx21/GATA-3 mRNA
expression was significantly higher in BBDP-rats vs. W-rats. This
was due to increased mRNA expression of Tbx21 in BBDP-rats as
compared to W-rats, while a trend towards decreased GATA-3
expression was found in BBDP-rats versus W-rats (results not
shown). ROR-C mRNA did not differ between BBDP and W-rats,
but was significantly lower in BBDR vs. W-rats.
Activation of monocytes in non-pregnant BBDP-rat
Since monocytes play an important role in immunological
adaptations during pregnancy, we also studied monocyte subsets
and activation. We observed a higher non-classical/classical
monocyte ratio in BBDP than in W-rats (Figure 4). This was due
to a lower percentage of classical monocytes and a higher percentage
of non-classical monocytes in BBDP vs. W-rats (not shown). The
monocyte activation status was further evaluated by expression of
CD4, which decreases upon activation [28]. Percentage of CD4+
classical monocytes tended to be lower in BBDP vs. W-rats.
Moreover, MFI of CD4 on classical and non-classical monocytes
was decreased in BBDP-rats as compared to W-rats.
Pregnancy-induced immune changes in BBDP-rats
Pregnancy-induced changes in leukocyte subsets are
more pronounced in BBDP-rats. In BBDP-rats, WBC-count
significantly increased during the course of pregnancy (slope
0.103?109; p = 0.03) (Table 2). This appeared to be due to an
increased percentage of granulocytes during the course of pregnancy
(slope 1.37; p = 0.0003). In Wistar-rats, the WBC-count did not
change during pregnancy, although percentage of granulocytes
increased (slope 0.73; p = 0.0012) and percentage of lymphocytes
decreased (slope20.79; p = 0.0009) during the course of pregnancy.
These changes in W-rats appeared to be less pronounced as
compared to BBDP-rats, since we observed a trend towards
significant different slopes (slope 1.37 vs. 0.73; p = 0.08 in
granulocytes and slope 21.63 vs. 20.65; p = 0.06 in lymphocytes).
Increased Th/Tc-ratio in pregnant BBDP-rats
As can be seen from figure 5A, little changes in T-lymphocyte
subsets are observed in pregnant vs. non-pregnant animals in all
three rat strains. Only, in BBDP-rats, Th/Tc-ratio increased
during the course of pregnancy (slope 0.223; p = 0.019).
Decreased stimulatory/inhibitory receptors on NK-cells in
pregnant BBDP-rats
Although, in BBDP-rats the percentage of NK-cells was not
affected by pregnancy, the MFI ratio CD161a/NKR-P1b decreased
in BBDP-rats during the course of pregnancy (slope 20.783;
p = 0.02). In W-rats, the percentage of NK-cells appeared to slightly
decrease during the course of pregnancy (slope 20.044; p = 0.09),
while the ratio MFI CD161a+/NKR-P1b+ remained stable.
Pregnancy increased the Th1/Th2 ratio in BBDP-rats
The Th1/Th2-ratio increased during the course of pregnancy
in BBDP (0.305; p = 0.045) and BBDR-rats (slope 0.061; p = 0.02),
but not in W-rats, resulting in a trend towards a significantly
steeper slope in BBDP vs. W-rats (p = 0.06; Fig. 5B). Expression of
ROR-C similarly decreased during the course of pregnancy in
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Increased ratio non-classical/classical monocytes during
pregnancy
As can be seen in figure 6, an increased ratio of non-classical/
classical monocytes was found in all three strains during the course of
pregnancy (BBDP: slope 0.043; p = 0.02, W: slope 0.022; p = 0.07,
BBDR: slope 0.070; p = 0.002). Although the percentages of CD4+
classical or non-classical monocytes and CD4-expression on classical
monocytes was not affected by pregnancy, CD4 expression on non-
classical monocytes decreased during the course of pregnancy in W-
rats (slope 20.51; p = 0.01), which was not observed in BBDP-rats.
The slopes of BBDP and BBDR-rats were significantly different
from the slope of W-rats (p = 0.003 and p = 0.002 respectively).
Discussion
In the present study we used BBDP-rats to evaluate adaptations of
the immune-response to pregnancy during type 1 diabetes under
normoglycemic conditions. The BBDP-rat is a generally well
accepted model for T1D and one of the most commonly used
T1D models among rodents [25]. These animals show a mutation in
the Gimap5 gene, which not only results in lymphopenia, but also in
Figure 3. Lymphocyte subpopulations in non-pregnant rats. [A] The percentages of T-lymphocytes (of the total leukocyte population), the
ratio of T-helper cells (Th) and cytotoxic T-cells (Tc), percentages effector T-cells (of Th; Teff), regulatory T-cells (of Th; Treg), NK-cells (of total
lymphocyte population) and the ratio of MFI CD161a/NKR-P1b of NK-cells of the three non-pregnant rat-strains. [B] The Th1/Th2-mRNA ratio and
mRNA expression of ROR-C of the three non-pregnant rat-strains. Values are expressed as median with range (Q1–Q3), mRNA was expressed as Fold
Change (2^2DCT). ‘*’ significant difference, Mann-Whitney U-Test, p,0.05.
doi:10.1371/journal.pone.0065490.g003
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decreased numbers of regulatory T cells. This is in line with our
findings (absolute numbers of lymphocytes and Treg are lower in
BBDP-rats as compared with the other groups). These changes are
important for the development of the autoimmunity and thus T1D
[29]. We questioned whether due to the presence of the autoimmune
disease in these BBDP-rats, the immunological adaptations to
pregnancy would be different as compared to healthy rats, resulting
in higher number of complications in the diabetic animals. Similar to
T1D in human pregnancy, we found less favorable pregnancy
outcome in BBDP-rats as compared to non-diabetic BBDR and W-
rats. These complications coincided with a different immune-
response in pregnant and non-pregnant BBDP-rats. The immune-
response in non-pregnant BBDP-rats is characterized by decreased
percentages of lymphocytes, increased percentages of Teff, Treg and
NK-cells, an increased Th1/Th2-ratio and activated monocytes
versus W and BBDR-rats. Furthermore, in BBDP-rats we found
different pregnancy-induced adaptations as compared to W and
BBDR-rats, i.e. an increased Th1/Th2-ratio, a decreased MFI
CD161a/NKR-P1b ratio in comparison with the adaptation in W-
rats. Moreover, in contrast to W-rats (in which monocytes were
activated during pregnancy), we found no further activation of
monocytes during pregnancy in BBDP-rats.
Despite the differences in immune-response between non-
pregnant BBDP-rats and non-pregnant W and BBDR-rats (i.e. the
immune-response at the start of pregnancy), all rat-strains are able
to become pregnant. However, adverse fetal outcome in BBDP-
rats was observed and characterized by lower fetal numbers, lower
fetal weight of living fetuses, lower placental weight and increased
numbers of resorptions versus our control rats. Interestingly,
BBDR-rats also showed lower number of fetuses and lower fetal
weight as compared to W-rats. This may coincide with the fact
that also these rats showed different immunological adaptations to
pregnancy as compared with W-rats, such as an increased Th1/
Th2-ratio and lack of activation of non-classical monocytes.
Pregnancy outcome in women with T1D is also associated with
adverse outcome [1,2]. However, pregnancy outcome parameters of
rats are not completely similar to human outcome parameters. For
instance, we observed decreased fetal weight in T1D rat pregnancy,
i.e. growth retardation, while human diabetic pregnancy is often
accompanied by macrosomia. This difference between humans and
rats is probably related to the fact that glucose levels in T1D rats were
better controlled then in T1D human pregnancy. T1D in human
pregnancy is associated with moderate hyperglycemic episodes,
despite relatively good glycemic regulation [1,5]. Indeed, previous
studies using rat models for diabetes, showed increased pup weight,
when glycemia was not well controlled [30,31]. The increased
numbers of resorptions in rat T1D pregnancy may be comparable to
miscarriage in humans (rats do resorb fetuses, rather than abort
them), which occurs more frequently in human T1D pregnancy. We
found a slightly decreased number of implantations sites. A
decreased number of implantation sites could indicate a diminished
number of fertilized oocytes or a decreased number of fertilized
oocytes that is able to implant. Immunological differences observed
in our study between diabetic and non-diabetic animals could play
an important role in development of the adverse pregnancy outcome
in BBDP-rats [7,32].
The increased Th1/Th2-ratio in non-pregnant BBDP-rats was
further increased during pregnancy in contrast to W-rats, since
Figure 4. Monocyte subpopulations in non-pregnant rats. The ratio of non-classical/classical monocytes [A], the percentage of CD4+ classical
monocytes [B], the MFI of CD4 on classical monocytes [C], the percentage of CD4+ non-classical monocytes [D] and the MFI of CD4 on non-classical
monocytes [E] in non-pregnant animals of each strain. Values expressed as median with range (Q1–Q3), ‘*’ significant difference, Mann-Whitney
U-Test, p,0.05.
doi:10.1371/journal.pone.0065490.g004
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these rats showed no changes in Th1/Th2-ratio during pregnancy.
In human pregnancy, such an increased Th1/Th2-ratio is
associated with recurrent miscarriage and fetal growth retardation
[10,15,18]. Indeed, in diabetic rats, we found increased resorptions
and decreased fetal weight. An upregulation of Th17 and
decreased number/function of Treg are also associated with
recurrent miscarriage and pre-eclampsia [33,34]. In our study, the
adaptations of Treg and ROR-C during pregnancy appeared to
be the same for BBDP and W-rats. This may suggest that these
cells do not play a role in fetal complications in BBDP-rats.
However, it has been shown that the function of Treg in BBDP-
rats is decreased [29,35]. If this is also the case in pregnant BBDP-
rats, such a decreased function could be involved in the fetal
complications seen in our model.
The increased percentage of NK-cells in non-pregnant BBDP-
rats, in contrast to W-rats, did not decrease during pregnancy.
Although minor knowledge is available about peripheral NK-cells
in rat pregnancy, healthy pregnant women showed reduced
numbers of peripheral NK-cells [11,36]. This is in line with the
observations in W-rats. Moreover, increased numbers of peripheral
NK-cells during human pregnancy have been associated with
recurrent spontaneous abortion [37]. This may suggest that
increased numbers of NK-cells in pregnant BBDP-rats may be
involved in increased numbers of resorptions in these rats. The
Figure 5. Lymphocyte subpopulations in pregnant rats. Values of day 10 or 18 of pregnancy are recalculated regarding the median values of
non-pregnant animals (which was set at 100%) to express (as median (Q1–Q3)) pregnancy-induced changes. [A] The adaptations to pregnancy in
percentage of T-lymphocytes, ratio of T-helper cells (Th) and cytotoxic T-cells (Tc), percentages of effector T-cells (Teff), regulatory T-cells (Treg), NK-
cells and the ratio of MFI CD161a/NKR-P1b of NK-cells in all three strains during pregnancy. [B] The adaptations to pregnancy of the Th1/Th2-mRNA
ratio and ROR-C mRNA expression in all three strains during pregnancy. d10/d18: day 10 or 18 of pregnancy. ‘slope significantly different from zero
(Regression-analysis, ANCOVA, p,0.05). *slope significant different between the marked strains (Regression-analysis, ANCOVA, p,0.05).
doi:10.1371/journal.pone.0065490.g005
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increased numbers of peripheral NK-cells in BBDP-rats may be due
to impaired migration of these cells to the maternal uterus where
they play an important role in preparing the uterine wall and
vasculature for trophoblast-invasion [38]. This decreased migration
of NK-cells in BBDP-rats could possibly lead to a less optimal
trophoblast-invasion and result in smaller fetuses or more fetal
resorptions. In rats, the receptors CD161a and NKR-P1b function
as stimulatory and inhibitory receptors respectively [39]. Therefore,
decreased CD161a/NKR-P1b expression ratio in BBDP-rats
during pregnancy indicates a shift towards inhibitory receptors.
Interestingly, it was suggested that an overexpression of inhibitory
receptors was associated with impaired trophoblast-invasion and
pre-eclampsia [14,40]. However, further studies are needed to
evaluate the role of these NK-cells in pregnancy of BBDP-rats.
In rats, monocyte subdivision into classical and non-classical
monocytes is based on CD43 expression [41]. Classical monocytes
(CD43+) are associated with extravasation to inflamed tissue where
they develop into macrophages and help with pathogen clearance
and wound healing [42]. Non-classical monocytes (CD43++) are
thought to play a role in replenishment of resident tissue
macrophages; they produce increased amounts of pro-inflamma-
tory cytokines [42,43]. Increased numbers of these monocytes are
seen in inflammatory conditions [43–45]. Non-pregnant BBDP
and BBDR-rats display a pro-inflammatory status as compared
with W-rats, judging from their increased ratio of non-classical/
classical monocytes. Also, the activational status of monocytes in
these rats was increased, i.e. CD4 expression was decreased [28].
During pregnancy, however, the ratio non-classical/classical
monocytes increased in all three rat strains as compared to non-
pregnant rats, which is in line with a previous study from our lab
[46]. Also the decreased expression of CD4 on non-classical
monocytes in pregnant W-rats indicates activation of these cells.
These observations corroborates the general accepted hypothesis
that pregnancy is associated with generalized activation of the
inflammatory response [47,48]. However, since the ratio non-
classical/classical monocytes in BBDP and BBDR-rats was already
higher as compared to W-rats before onset of pregnancy, the
similar increase of this ratio in all three rat-strains during
pregnancy results in higher activation of monocytes during
pregnancy in BB-rats as compared with W-rats. Such a further
activation of the inflammatory response in human pregnancy is
associated with pre-eclampsia, recurrent pregnancy loss and
preterm labor [14–16].
In conclusion, this study has shown that the peripheral immune-
response in non-pregnant BBDP-rats, i.e. at the start of pregnancy,
is different compared with the control rats. We also observed
different adaptations of the immune-response to pregnancy in
these BBDP-rats. Since aberrant immunological adaptations to
pregnancy are associated with maternal and perinatal complica-
tions, it may be suggested that the observed decreased number of
fetuses, lower fetal weight, lower placental weight and more
resorptions in BBDP-rats are a consequence of these different
immunological adaptations. This suggestion corresponds with data
on human pregnancy in patients with other autoimmune diseases,
such as rheumatoid arthritis or systemic lupus erytematosus, in
which the presence of the autoimmune disease results in
Figure 6. Monocyte subpopulations in pregnant rats. Values of day 10 or 18 of pregnancy are recalculated regarding the median values of
non-pregnant animals (which was set at 100%) to express (as median (Q1–Q3)) pregnancy-induced changes. [A] The adaptations to pregnancy in the
ratio non-classical/classical monocytes, [B] the percentage of CD4+ classical monocytes, [C] the MFI of CD4 on classical monocytes, [D] the percentage
of CD4+ non-classical monocytes and [E] the MFI of CD4 on non-classical monocytes of each strain during pregnancy. d10/d18: day 10 or 18 of
pregnancy. ‘slope significantly different from zero (Regression-analysis, ANCOVA, p,0.05). *slope significant different between the marked strains
(Regression-analysis, ANCOVA, p,0.05).
doi:10.1371/journal.pone.0065490.g006
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complications, such as recurrent miscarriages, decreased birth
weight and preterm birth [49–51]. Therefore, it may be postulated
that the immune process in patients with T1D is, besides
hyperglycemia, also responsible for the adverse pregnancy
outcome. The present study was an observational study in rats,
performed to substantiate our hypothesis that factors associated
with the presence of an autoimmune disease are involved in
pregnancy complications observed in diabetic pregnancies. Since
our data suggest different immune responses between control and
T1D rats, further mechanistically insights into the role of various
immune cells in implantation, placental and fetal development in
healthy and diabetic pregnancy is necessary, as well as conforma-
tion of these results in human pregnancy.
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